Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events: results of a long-term follow-up study in routine clinical care

被引：0
|
作者：
Dietrich Rothenbacher
Michael M Hoffmann
Lutz P Breitling
Iris Rajman
Wolfgang Koenig
Hermann Brenner
机构：
[1] Ulm University,Institute of Epidemiology and Medical Biometry
[2] German Cancer Research Center,Division of Clinical Epidemiology & Aging Research
[3] University Medical Center Freiburg,Department of Clinical Chemistry
[4] Novartis Institute of Biomedical Research,Department of Internal Medicine II
[5] University of Ulm Medical Center,Cardiology
来源：
BMC Cardiovascular Disorders | / 13卷
关键词：
Percutaneous Coronary Intervention; Clopidogrel; Coronary Artery Bypass Grafting; Prasugrel; Ticagrelor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 33 条
  • [21] Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study
    Yu, Luhai
    Wang, Tingting
    Bai, Huidong
    Zhu, Weijiang
    Li, Yanju
    Wu, Jianhua
    Liu, Wenli
    Sun, Li
    Yu, Aiping
    Li, Hongjian
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [22] Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II) - Final 2-Year Follow-up Results of a Postmarketing Observational Study -
    Nakamura, Masato
    Kitazono, Takanari
    Kozuma, Ken
    Sekine, Toru
    Nakamura, Shinya
    Shiosakai, Kazuhito
    Tanabe, Ayumi
    Iizuka, Tomoko
    CIRCULATION JOURNAL, 2020, 84 (11) : 1981 - +
  • [23] Cytochrome P450 2C19 Polymorphisms and Its Association With Major Adverse Cardiac Events in Post-coronary Intervention Patients on Clopidogrel in the Tertiary Care Center
    Kambhampati, Nikhil Teja
    Ahamed, Hisham
    Velayudhan, K. K.
    David, Sachin
    Hakeem, Sai Chandra
    Pillai, Gopalakrishna
    Kartha, Niveditha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [24] The impact of cytochrome P450 2C19 polymorphism on the occurrence of one-year in-stent restenosis in patients who underwent percutaneous coronary intervention: A case-match study
    Nozari, Younes
    Vosooghi, Sirous
    Boroumand, Mohammadali
    Poorhosseini, Hamidreza
    Nematipour, Ebrahim
    Salarifar, Mojtaba
    Kassaian, Seyed Ebrahim
    Amirzadegan, Alireza
    Alidoosti, Mohammad
    Haji-Zeinali, Ali-Mohammad
    Saroukhani, Sepideh
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2015, 15 (05) : 348 - 353
  • [25] Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II)-1-Year Follow-up Results of a Postmarketing Observational Study -
    Nakamura, Masato
    Kitazono, Takanari
    Kozuma, Ken
    Sekine, Toru
    Nakamura, Shinya
    Shiosakai, Kazuhito
    Iizuka, Tomoko
    CIRCULATION JOURNAL, 2020, 84 (01) : 101 - +
  • [26] Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China
    Zhixiong Zhong
    Jingyuan Hou
    Qifeng Zhang
    Bin Li
    Cunren Li
    Zhidong Liu
    Min Yang
    Wei Zhong
    Xuebo He
    Hesen Wu
    Miaocai Zhong
    Pingsen Zhao
    European Journal of Clinical Pharmacology, 2018, 74 : 423 - 431
  • [27] Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China
    Zhong, Zhixiong
    Hou, Jingyuan
    Zhang, Qifeng
    Li, Bin
    Li, Cunren
    Liu, Zhidong
    Yang, Min
    Zhong, Wei
    He, Xuebo
    Wu, Hesen
    Zhong, Miaocai
    Zhao, Pingsen
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (04) : 423 - 431
  • [28] Polyunsaturated omega-3 fatty acids improve responsiveness to clopidogrel after percutaneous coronary intervention in patients with cytochrome P450 2C19 loss-of-function polymorphism
    Gajos, Grzegorz
    Zalewski, Jaroslaw
    Nessler, Jadwiga
    Zmudka, Krzysztof
    Undas, Anetta
    Piwowarska, Wieslawa
    KARDIOLOGIA POLSKA, 2012, 70 (05) : 439 - 446
  • [29] Prasugrel effectively reduces the platelet reactivity units in patients with genetically metabolic dysfunction of cytochrome P450 2C19 who are treated with long-term dual antiplatelet therapy after undergoing drug-eluting stent implantation
    Shimamatsu, Junichiro
    Sasaki, Ken-ichiro
    Katsuki, Yoshio
    Kawasaki, Tomohiro
    Murasato, Yoshinobu
    Ajisaka, Hidehiko
    Yokoi, Hiroyoshi
    Tashiro, Hideki
    Harada, Atsushi
    Hirakawa, Yuji
    Ishizaki, Yuta
    Ishimatsu, Takashi
    Kagiyama, Kotaro
    Fukumoto, Yoshihiro
    Kakuma, Tatsuyuki
    Ueno, Takafumi
    HEART AND VESSELS, 2020, 35 (03) : 312 - 322
  • [30] Prasugrel effectively reduces the platelet reactivity units in patients with genetically metabolic dysfunction of cytochrome P450 2C19 who are treated with long-term dual antiplatelet therapy after undergoing drug-eluting stent implantation
    Junichiro Shimamatsu
    Ken-ichiro Sasaki
    Yoshio Katsuki
    Tomohiro Kawasaki
    Yoshinobu Murasato
    Hidehiko Ajisaka
    Hiroyoshi Yokoi
    Hideki Tashiro
    Atsushi Harada
    Yuji Hirakawa
    Yuta Ishizaki
    Takashi Ishimatsu
    Kotaro Kagiyama
    Yoshihiro Fukumoto
    Tatsuyuki Kakuma
    Takafumi Ueno
    Heart and Vessels, 2020, 35 : 312 - 322
1234